MA
55
-7
GOOGL
54
-2
ACN
47
-2
AMP
69
-3
LH
42
2
PSA
51
-4
NAVI
41
-3
PX
75
5
JPM
63
-4
EQT
59
2
TGT
25
-24
CMCSA
48
2
DHR
35
3
NWS
62
-2
CSCO
63
2
HP
38
-2
CVX
46
5
HON
65
-2
BBY
40
3
HOG
29
-4
MA
55
-7
GOOGL
54
-2
ACN
47
-2
AMP
69
-3
LH
42
2
PSA
51
-4
NAVI
41
-3
PX
75
5
JPM
63
-4
EQT
59
2
TGT
25
-24
CMCSA
48
2
DHR
35
3
NWS
62
-2
CSCO
63
2
HP
38
-2
CVX
46
5
HON
65
-2
BBY
40
3
HOG
29
-4
Financhill
Back

Cue Biopharma Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
16

CUE
Cue Biopharma

Last Price:
1.04
Seasonality Move:
13.31%
Buy
57

BMRN
Biomarin Pharmaceutical

Last Price:
63.44
Seasonality Move:
12.47%
Sell
16
Cue Biopharma (CUE) is a Sell

Is Cue Biopharma a Buy, Sell or Hold?

  • The current Cue Biopharma [CUE] share price is $1.09. The Score for CUE is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • CUE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
57
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $62.56. The Score for BMRN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CUE Stock Price Chart

What is Cue Biopharma's stock price today?

  • The Cue Biopharma share price today is $1.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $62.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

CUE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 39.31 Sell
Chaikin Money Flow: -136595 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.28 - 1.76) Sell
Bollinger Bands (100): (0.57 - 1.35) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.16 Sell
Relative Strength Index (14 RSI): 27.46 Sell
Chaikin Money Flow: 863717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.41 - 69.77) Sell
Bollinger Bands (100): (68.48 - 87.38) Sell

CUE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.38 Sell
20-day SMA: 1.54 Sell
50-day SMA: 1.16 Sell
200-day SMA: 1.39 Sell
8-day EMA: 1.3 Sell
20-day EMA: 1.41 Sell
50-day EMA: 1.26 Sell
200-day EMA: 1.46 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.33 Sell
20-day SMA: 66.31 Sell
50-day SMA: 69.39 Sell
200-day SMA: 81.31 Sell
8-day EMA: 63.89 Sell
20-day EMA: 65.94 Sell
50-day EMA: 70.23 Sell
200-day EMA: 79.7 Sell

Cue Biopharma Earnings Growth & CUE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Cue Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):